64 results
424B5
STRO
Sutro Biopharma Inc
2 Apr 24
Prospectus supplement for primary offering
4:58pm
existing cash to achieve our business goals, business strategy, market size for our product candidates, potential future milestone and royalty payments
8-K
EX-99.1
STRO
Sutro Biopharma Inc
2 Apr 24
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
6:04am
and targets contained herein are based on Ipsen’s management strategy, current views and assumptions. Such statements involve known and unknown risks
8-K
EX-99.1
bmor0hib00c184h l8
8 Jan 24
Results of Operations and Financial Condition
7:31am
8-K
EX-99.1
qxdqwf9t252r43ae dl0
21 Nov 23
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.1
holwk dxq6gu
15 May 23
Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
8:01am
PRE 14A
in8pk s0w2dzef
14 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.1
kdma 5iwe
30 Mar 23
Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones
4:32pm
8-K
EX-99.1
dnsccf5durlmyv 7dzxa
27 Jun 22
Entry into a Material Definitive Agreement
7:31pm